Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Assembly Biosciences Inc (NASDAQ:ASMB)

44.39
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
11.07
Today|||52-Week Range
52.37
+265.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$772.3M

Company Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics designed to restore health to a dysbiotic microbiome. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

Contact Information

Assembly Biosciences, Inc.
11711 North Meridiyan Street
Carmel Indiana 46032
P:(855) 971-4467
Investor Relations:
(415) 521-3828

Employees

Shareholders

Other institutional70.37%
Mutual fund holders18.35%
Individual stakeholders16.95%

Top Executives

Derek A. SmallPresident, Chief Executive Officer & Director
David J. BarrettCFO, COO & Principal Accounting Officer
Uri A. LopatinChief Medical Officer, VP-Research & Development
Richard J. ColonnoChief Scientific Officer
Hong Mei HuangVP-Information Technology & Informatics